Is cD46 expression indicative of shorter revival-free survival for ovarian cancer patients?
Ovarian cancers manifest CD46 expression that is linked to a less favourable prognosis.
In our experience, the incidence of amniocentesis-related adverse outcomes is not increased in diamniotic twins compared to singleton pregnancies.